Autres langues PharmaCielo Ltd.

Actions

PCLO

CA71716K1012

Marché Fermé - Toronto S.E. Autres places de cotation 21:04:20 02/05/2024			Varia. 5j.	Varia. 1 janv.
0,175 ^CAD	-5,41%		+6,06%	-2,78%

04/01	Benuvia et PharmaCielo annoncent un partenariat stratégique pour la fabrication d'isolat de CBD de qualité pharmaceutique cGMP et de produits connexes	CI
2023	PharmaCielo Ltd. déclare ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors	10/04
PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding	10/04
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil	26/03
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo	01/03
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	04/01
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	04/01
PharmaCielo Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
PharmaCielo Announces Q3 2023 Financial Results	29/11
PharmaCielo Raises $3.3 Million Under Non-Brokered Private Placement	06/10/23
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement	06/10/23
PharmaCielo Ltd. announced that it has received CAD 4.78 million in funding	06/10/23
PharmaCielo Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23
Pharmacielo Ltd. Appoints Marc Lustig as CEO	11/07/23
Pharmacielo Ltd. Announces Board Changes	11/07/23
PharmaCielo Ltd. announced that it expects to receive CAD 5 million in funding	29/06/23
PharmaCielo Ltd. announced that it has received CAD 12.825 million in funding	29/06/23
PharmaCielo Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	29/05/23
PharmaCielo Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	01/05/23
PharmaCielo Ltd. Auditor Raises 'Going Concern' Doubt	01/05/23
PharmaCielo Receives Purchase Order for API from Brazilian Pharmaceutical Company Represents Third Customer in the Country	09/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PharmaCielo Ltd.

Actions

PCLO

CA71716K1012

Autres langues

Filtres